Budget Impact Analysis of Expanding Gliflozin Coverage in the CKD Population: A French Perspective

INTRODUCTION: Gliflozins have historically been indicated for type 2 diabetes in France. However, their efficacy has recently been demonstrated in heart failure and chronic kidney disease (CKD), with positive recommendations by Haute Autorité de Santé for gliflozin therapies in these indications. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: de Pouvourville, Gérard, Rossignol, Patrick, Boussahoua, Meriem, Chevalier, Julie, Gabb, Peter D., Poulnais, Roch, Verboux, Dorian, Rao, Naveen, Sörstadius, Elisabeth, Garcia Sanchez, Juan Jose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427519/
https://www.ncbi.nlm.nih.gov/pubmed/37341914
http://dx.doi.org/10.1007/s12325-023-02574-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10427519/
https://www.ncbi.nlm.nih.gov/pubmed/37341914
http://dx.doi.org/10.1007/s12325-023-02574-2

Ejemplares similares